维普期刊资源整合服务平台（V6.5）

86篇 您的检索式：作者名="Yaccoby"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Antibody-based inhibition of DKKI suppresses tumor-induced bone resorption and multiple myeloma growth in vivo显示文摘	YACCOBY S LING W ZHAN F	2007	Blood2007，109，5：	1
2	Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins 显示文摘	Borset M Hjertner O Yaccoby S	2000	Blood2000，96，7：	1
3	Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple Myelom a growth in vivo显示文摘	Yaccoby S Ling W Zhan F	2007	Blood2007，109，5：	1
4	Sydecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding protein 显示文摘	Borset M Yaccoby S Epstein J	2000	Blood2000，96，7：	1
5	Targeting β 2 -microglobulin for induction of tumor apoptosis in human hematological malignancies显示文摘	Jing Yang Jianfei Qian Michele Wezeman Siqing Wang Pei Lin Michael Wang Shmuel Yaccoby Larry W. Kwak Bart Barlogie Qing Yi	2006	Cancer Cell2006，，4：	1
6	A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients 显示文摘	Zangari M Yaccoby S Pappas L	2011	Haematologica2011，96，：	1
7	Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and myelomatous mice 显示文摘	Yaccoby S Wezeman M J Zangari M	2006	Haematologica2006，91，2：	1
8	Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins显示文摘	Borset M Hjertner O Yaccoby S	2000	Blood2000，96，7：	1
9	Antibody basedinhibition of DKKl suppresses tumor-induced boneresorption and multiple myeloma growth in vivo显示文摘	Yaccoby S Ling W Zhan F	2007	Blood2007，109，5：	1
10	Soluble syndecan-1 promotes growth of myeloma tumors in vivo显示文摘	Yang Y Yaccoby S Liu W	2002	Blood2002，100，2：	1
11	Primary myeloma cells growing in SCID-hu mice:a model for studying the biology and treatment of myeloma and its manifestations显示文摘	Yaccoby S Barlogie B Epstein J	1998	Blood1998，92，8：	1
12	The proliferative potential of myeloma plasma cells manifest in the SCID-hu host显示文摘	Yaccoby S Epstein J	1999	Blood1999，94，10：	1
13	Cancer and the microenvironment: myeloma osteoclast interactions as a model显示文摘	Yaccoby S Wezeman M J Henderson A etal	2004	Cancer Res2004，64，6：	1
14	Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth显示文摘	Qiang Y W Shaughnessy J D Yaccoby S	2008	Blood2008，112，2：	1
15	Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo显示文摘	Yaccoby S Ling W Zhan F	2007	Blood2007，109，5：	1
16	Advances in the understanding of myeloma bone disease and tumour growth 显示文摘	Yaccoby S	2010	Br J Haematol2010，149，3：	1
17	The proliferative potential of myeloma plasma cells manifest in the SCID-hu host显示文摘	Yaccoby S Epstein J	1999	Blood1999，94，10：	1
18	Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression显示文摘	Pearse R N Sordillo E M Yaccoby S	2001	Proc Natl Acad Sci USA2001，98，11：	1
19	Response to bortezomib and activation of osteoblasts in multiple myeloma 显示文摘	Zangari M Yaccoby S Cavallo F	2006	Clin Lymphoma Myeloma2006，7，2：	1
20	The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype 显示文摘	Yaccoby S	2005	Clin Cancer Res2005，1，21：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示